Search
for
Sort by
Research 241–270 of 1000+
- Off-label dermatologic uses of IL-23 inhibitors
- Evidence of a Causal Relationship Between Body Mass Index and Immune-Mediated and Inflammatory Skin Diseases and Biomarkers: A Mendelian Randomization Study
- Medical Dermatology
- Association between metabolic syndrome and prevalent skin diseases: A systematic review and meta‐analysis of case‐control studies
- Vulvar Fordyce adenitis: A cohort of 45 women
- Nuevas poblaciones con riesgo cardiovascular aumentado: enfermedad cardiovascular en las enfermedades dermatológicas
- Viewpoint 1
- Benefit-Risk Assessment of GLP-1 Receptor Agonists: Implications for Dermatologists and Plastic Surgeons
- Dermatological adverse reactions and therapeutic potential of semaglutide, liraglutide and tirzepatide: Analysis of UK pharmacovigilance data and literature review
- New Perspectives on Nutraceutical Insulin Sensitizing Agents in the Treatment of Psoriasis and Other Dermatological Diseases
- Steatocystoma Multiplex
- Non-FDA-Approved Uses of Apremilast in Dermatology: A Review of Current Available literature
- LB943 Tofacitinib treatment of inflammatory skin conditions in patients with Down Syndrome
- Annual Convention in the Time of COVID
- Disorders of the Hair and Nails
- Viewpoint 4
- Clascoterone in the Treatment of Acne Vulgaris: A Narrative Review
- Skin Impacts and Tradeoffs of GLP-1 Therapy: Improved Patient-Reported Outcomes of Inflammatory Skin Disease in the Era of “Ozempic Face”
- The follicular microbiome in hair-follicle-associated inflammatory diseases: A systematic review
- Transcriptional and epigenetic mechanisms governing epidermal stem cell regulation
- Editorial: Exploring innovative therapies for rare inflammatory skin diseases
- Iron Deficiency in Immune-Mediated Inflammatory Skin Diseases: A Missing Link Between Systemic Inflammation, Immunometabolism, and Disease Burden
- Managing Skin Diseases that Flare During Pregnancy and in the Postpartum period: Part 2- Management & Safety Considerations
- Semaglutide and the Skin: An Overview of Current Evidence
- Viable vs. Nonviable Microbiota Evaluation of the Hair Follicle and Scalp Microbiome
- Metabolic aging and cutaneous markers of metabolic syndrome: a narrative review
- Directional Association Between Irritable Bowel Syndrome and Dermatological Disease: A Large-Scale Retrospective Study
- DERMATOLOGICAL CONDITIONS IN TRANSGENDER PATIENTS: A SYSTEMATIC REVIEW
- Inflammatory Skin Disease in Latin America: Treatment Challenges and Opportunities
- The Impact of Bariatric Surgery on the Development and Progression of Dermatologic Diseases: A Narrative Review